United States · FDA National Drug Code directory
Atracurium Besylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55150-217_12db80ae-2d05-4941-8c95-8ff454a31d80
- Product NDC
- 55150-217
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Atracurium Besylate
- Labeler
- AuroMedics Pharma LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150408
- Source listing expiry
- 20261231
Source-listed ingredients
- ATRACURIUM BESYLATE — 100 mg/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, MULTI-DOSE in 1 CARTON (55150-217-10) / 10 mL in 1 VIAL, MULTI-DOSE · 55150-217-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →